Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01186692 · ClinicalTrials.gov registry record · NA
Melody® Transcatheter Pulmonary Valve Post-Approval Study
A NA study, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- NA
- Development phase
- 131
- Enrollment target
NCT01186692 is a NA study that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 131 participants.
The verdict
NCT01186692, a NA study, has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
Study Summary
The purpose of this study is to confirm the short-term hemodynamic effectiveness results achieved by real-world providers are equivalent to the historical control established in the IDE study.
Interventions
- DEVICE Melody® Transcatheter Pulmonary Valve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2010-07 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01186692
The ClinicalTrials.gov registry entry for NCT01186692 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Melody® Transcatheter Pulmonary Valve is the first listed.
NCT01186692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01186692 about?
NCT01186692 is a clinical study titled "Melody® Transcatheter Pulmonary Valve Post-Approval Study". The purpose of this study is to confirm the short-term hemodynamic effectiveness results achieved by real-world providers are equivalent to the historical control established in the IDE study.
What is the current status of trial NCT01186692?
This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2010-07. Estimated completion is 2017-10.
What interventions are being tested in trial NCT01186692?
The interventions under investigation include: Melody® Transcatheter Pulmonary Valve (DEVICE).
Who is sponsoring clinical trial NCT01186692?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.